Mati Fridkin - Publications

Affiliations: 
ORG Organic Chemistry Weizmann Institute of Science, Rehovot, Israel 
Area:
Organic Chemistry, Pharmacy, Oncology

188 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Cooper I, Atrakchi D, Walker MD, Horovitz A, Fridkin M, Shechter Y. Converting bleomycin into a prodrug that undergoes spontaneous reactivation under physiological conditions. Toxicology and Applied Pharmacology. 114782. PMID 31655077 DOI: 10.1016/j.taap.2019.114782  0.44
2016 Cooper I, Fridkin M, Shechter Y. Conjugation of Methotrexate-Amino Derivatives to Macromolecules through Carboxylate Moieties Is Superior Over Conventional Linkage to Amino Residues: Chemical, Cell-Free and In Vitro Characterizations. Plos One. 11: e0158352. PMID 27403959 DOI: 10.1371/journal.pone.0158352  0.52
2015 Zheng H, Fridkin M, Youdim M. New approaches to treating Alzheimer's disease. Perspectives in Medicinal Chemistry. 7: 1-8. PMID 25733799 DOI: 10.4137/PMC.S13210  0.52
2015 Cooper I, Last D, Guez D, Sharabi S, Elhaik Goldman S, Lubitz I, Daniels D, Salomon S, Tamar G, Tamir T, Mardor R, Fridkin M, Shechter Y, Mardor Y. Combined local blood-brain barrier opening and systemic methotrexate for the treatment of brain tumors. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 35: 967-76. PMID 25669901 DOI: 10.1038/jcbfm.2015.6  0.52
2014 Zheng H, Fridkin M, Youdim M. From single target to multitarget/network therapeutics in Alzheimer's therapy. Pharmaceuticals (Basel, Switzerland). 7: 113-35. PMID 24463342 DOI: 10.3390/ph7020113  0.52
2012 Cooper I, Sasson K, Teichberg VI, Schnaider-Beeri M, Fridkin M, Shechter Y. Peptide derived from HIV-1 TAT protein destabilizes a monolayer of endothelial cells in an in vitro model of the blood-brain barrier and allows permeation of high molecular weight proteins. The Journal of Biological Chemistry. 287: 44676-83. PMID 23150670 DOI: 10.1074/jbc.M112.395384  0.52
2012 Shechter Y, Sasson K, Marcus Y, Rubinraut S, Lev-Goldman V, Fridkin M. Establishing the principle of reversibility in peptide/protein and small-molecule therapy. Therapeutic Delivery. 3: 17-23. PMID 22833930 DOI: 10.4155/tde.11.133  0.52
2012 Shechter Y, Sasson K, Lev-Goldman V, Rubinraut S, Rubinstein M, Fridkin M. Newly designed modifier prolongs the action of short-lived peptides and proteins by allowing their binding to serum albumin. Bioconjugate Chemistry. 23: 1577-86. PMID 22759320 DOI: 10.1021/bc3000854  0.52
2012 Zheng H, Fridkin M, Youdim MB. Novel chelators targeting cell cycle arrest, acetylcholinesterase, and monoamine oxidase for Alzheimer's therapy. Current Drug Targets. 13: 1089-106. PMID 22676912 DOI: 10.2174/138945012802008982  0.52
2012 Zheng H, Fridkin M, Youdim MBH. From antioxidant chelators to site-activated multi-target chelators targeting hypoxia inducing factor, beta-amyloid, acetylcholinesterase and monoamine oxidase A/B Mini-Reviews in Medicinal Chemistry. 12: 364-370. PMID 22303968  0.52
2011 Blank M, Baraam L, Eisenstein M, Fridkin M, Dardik R, Heldman Y, Katchalski-Katzir E, Shoenfeld Y. β2-Glycoprotein-I based peptide regulate endothelial-cells tissue-factor expression via negative regulation of pGSK3β expression and reduces experimental-antiphospholipid-syndrome. Journal of Autoimmunity. 37: 8-17. PMID 21524885 DOI: 10.1016/j.jaut.2011.02.008  0.52
2010 Zheng H, Youdim MB, Fridkin M. Selective acetylcholinesterase inhibitor activated by acetylcholinesterase releases an active chelator with neurorescuing and anti-amyloid activities. Acs Chemical Neuroscience. 1: 737-46. PMID 22778810 DOI: 10.1021/cn100069c  0.52
2010 Zheng H, Fridkin M, Youdim MB. Site-activated chelators derived from anti-Parkinson drug rasagiline as a potential safer and more effective approach to the treatment of Alzheimer's disease. Neurochemical Research. 35: 2117-23. PMID 20981484 DOI: 10.1007/s11064-010-0293-1  0.52
2010 Zheng H, Youdim MB, Fridkin M. Site-activated chelators targeting acetylcholinesterase and monoamine oxidase for Alzheimer's therapy. Acs Chemical Biology. 5: 603-10. PMID 20455574 DOI: 10.1021/cb900264w  0.52
2010 Rubin N, Perugia E, Wolf SG, Klein E, Fridkin M, Addadi L. Relation between serum amyloid A truncated peptides and their suprastructure chirality. Journal of the American Chemical Society. 132: 4242-8. PMID 20218685 DOI: 10.1021/ja909345p  0.52
2010 Sasson K, Marcus Y, Lev-Goldman V, Rubinraut S, Fridkin M, Shechter Y. Engineering prolonged-acting prodrugs employing an albumin-binding probe that undergoes slow hydrolysis at physiological conditions. Journal of Controlled Release : Official Journal of the Controlled Release Society. 142: 214-20. PMID 19883707 DOI: 10.1016/j.jconrel.2009.10.028  0.52
2010 Gal S, Zheng H, Fridkin M, Youdim MB. Restoration of nigrostriatal dopamine neurons in post-MPTP treatment by the novel multifunctional brain-permeable iron chelator-monoamine oxidase inhibitor drug, M30. Neurotoxicity Research. 17: 15-27. PMID 19609632 DOI: 10.1007/s12640-009-9070-9  0.52
2009 Zheng H, Youdim MB, Fridkin M. Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective-neurorestorative moieties for Alzheimer's therapy. Journal of Medicinal Chemistry. 52: 4095-8. PMID 19485411 DOI: 10.1021/jm900504c  0.52
2009 Kasher R, Bajayo A, Gabet Y, Nevo N, Fridkin M, Katchalski-Katzir E, Kohen F, Bab I. Restrain of bone growth by estrogen-mimetic peptide-1 (EMP-1): a micro-computed tomographic study. Peptides. 30: 1181-6. PMID 19463753 DOI: 10.1016/j.peptides.2009.02.019  0.52
2009 Perugia E, Monticelli E, Rubinraut S, Kapitkovsky A, Fridkin M. The amyloidogenic domains of the human serum amyloid A protein--new insights. Advances in Experimental Medicine and Biology. 611: 69-70. PMID 19400097 DOI: 10.1007/978-0-387-73657-0_30  0.52
2008 Marcus Y, Sasson K, Fridkin M, Shechter Y. Turning low-molecular-weight drugs into prolonged acting prodrugs by reversible pegylation: a study with gentamicin. Journal of Medicinal Chemistry. 51: 4300-5. PMID 18578475 DOI: 10.1021/jm8002558  0.52
2008 Lev-Goldman V, Mester B, Ben-Aroya N, Hanoch T, Rupp B, Stanoeva T, Gescheidt G, Seger R, Koch Y, Weiner L, Fridkin M. Conjugates of gonadotropin releasing hormone (GnRH) with carminic acid: Synthesis, generation of reactive oxygen species (ROS) and biological evaluation. Bioorganic & Medicinal Chemistry. 16: 6789-98. PMID 18571926 DOI: 10.1016/j.bmc.2008.05.057  0.52
2008 Trebicz-Geffen M, Robinson D, Evron Z, Glaser T, Fridkin M, Kollander Y, Vlodavsky I, Ilan N, Law KF, Cheah KS, Chan D, Werner H, Nevo Z. The molecular and cellular basis of exostosis formation in hereditary multiple exostoses. International Journal of Experimental Pathology. 89: 321-31. PMID 18452536 DOI: 10.1111/j.1365-2613.2008.00589.x  0.52
2008 Rubin N, Perugia E, Goldschmidt M, Fridkin M, Addadi L. Chirality of amyloid suprastructures. Journal of the American Chemical Society. 130: 4602-3. PMID 18338897 DOI: 10.1021/ja800328y  0.52
2008 Cohen N, Stolarsky-Bennun M, Amir-Kroll H, Margalit R, Nussbaum G, Cohen-Sfady M, Pevsner-Fischer M, Fridkin M, Bercovier H, Eisenbach L, Jung S, Cohen IR. Pneumococcal capsular polysaccharide is immunogenic when present on the surface of macrophages and dendritic cells: TLR4 signaling induced by a conjugate vaccine or by lipopolysaccharide is conducive. Journal of Immunology (Baltimore, Md. : 1950). 180: 2409-18. PMID 18250450  0.52
2008 Blat D, Weiner L, Youdim MB, Fridkin M. A Novel iron-chelating derivative of the neuroprotective peptide NAPVSIPQ shows superior antioxidant and antineurodegenerative capabilities. Journal of Medicinal Chemistry. 51: 126-34. PMID 18078312 DOI: 10.1021/jm070800l  0.52
2008 Nesher M, Vachutinsky Y, Fridkin G, Schwarz Y, Sasson K, Fridkin M, Shechter Y, Lichtstein D. Reversible pegylation prolongs the hypotensive effect of atrial natriuretic peptide. Bioconjugate Chemistry. 19: 342-8. PMID 18069777 DOI: 10.1021/bc700294w  0.52
2008 Dangoor D, Biondi B, Gobbo M, Vachutinski Y, Fridkin M, Gozes I, Rocchi R. Novel glycosylated VIP analogs: synthesis, biological activity, and metabolic stability. Journal of Peptide Science : An Official Publication of the European Peptide Society. 14: 321-8. PMID 17924396 DOI: 10.1002/psc.932  0.52
2007 Blank M, Anafi L, Zandman-Goddard G, Krause I, Goldman S, Shalev E, Cervera R, Font J, Fridkin M, Thiesen HJ, Shoenfeld Y. The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model. International Immunology. 19: 857-65. PMID 17576752 DOI: 10.1093/intimm/dxm052  0.52
2007 Dangoor D, Rubinraut S, Fridkin M, Gozes I. Novel analogs of VIP with multiple C-terminal domains. Peptides. 28: 1622-30. PMID 17481779 DOI: 10.1016/j.peptides.2007.03.014  0.52
2006 Zheng H, Blat D, Fridkin M. Novel neuroprotective neurotrophic NAP analogs targeting metal toxicity and oxidative stress: Potential candidates for the control of neurodegenerative diseases Journal of Neural Transmission, Supplement. 163-172. PMID 17447427  0.52
2006 Gal S, Fridkin M, Amit T, Zheng H, Youdim MB. M30, a novel multifunctional neuroprotective drug with potent iron chelating and brain selective monoamine oxidase-ab inhibitory activity for Parkinson's disease. Journal of Neural Transmission. Supplementum. 447-56. PMID 17017567  0.52
2006 Dangoor D, Rubinraut S, Fridkin M, Gozes I. Novel extended and branched N-terminal analogs of VIP. Regulatory Peptides. 137: 42-9. PMID 16962672 DOI: 10.1016/j.regpep.2006.02.010  0.52
2006 Lev-Goldman V, Mester B, Ben-Aroya N, Koch Y, Weiner L, Fridkin M. Synthesis and active oxygen generation by new emodin derivatives and their gonadotropin-releasing hormone conjugates. Bioconjugate Chemistry. 17: 1008-16. PMID 16848409 DOI: 10.1021/bc050293r  0.52
2006 Scolnik Y, Portnaya I, Cogan U, Tal S, Haimovitz R, Fridkin M, Elitzur AC, Deamer DW, Shinitzky M. Subtle differences in structural transitions between poly-L- and poly-D-amino acids of equal length in water. Physical Chemistry Chemical Physics : Pccp. 8: 333-9. PMID 16482275 DOI: 10.1039/b513974k  0.52
2006 Fridkin G, Rahimipour S, Ben-Aroya N, Kapitkovsky A, Di-Segni S, Rosenberg M, Kustanovich I, Koch Y, Gilon C, Fridkin M. Novel cyclic azo-bridged analogs of gonadotropin-releasing hormone. Journal of Peptide Science : An Official Publication of the European Peptide Society. 12: 106-15. PMID 16059965 DOI: 10.1002/psc.696  0.52
2005 Zheng H, Youdim MB, Weiner LM, Fridkin M. Novel potential neuroprotective agents with both iron chelating and amino acid-based derivatives targeting central nervous system neurons. Biochemical Pharmacology. 70: 1642-52. PMID 16226724 DOI: 10.1016/j.bcp.2005.09.003  0.52
2005 Gal S, Zheng H, Fridkin M, Youdim MB. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion. Journal of Neurochemistry. 95: 79-88. PMID 16181414 DOI: 10.1111/j.1471-4159.2005.03341.x  0.52
2005 Zheng H, Gal S, Weiner LM, Bar-Am O, Warshawsky A, Fridkin M, Youdim MB. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition. Journal of Neurochemistry. 95: 68-78. PMID 16181413 DOI: 10.1111/j.1471-4159.2005.03340.x  0.52
2005 Zheng H, Youdim MB, Weiner LM, Fridkin M. Synthesis and evaluation of peptidic metal chelators for neuroprotection in neurodegenerative diseases. The Journal of Peptide Research : Official Journal of the American Peptide Society. 66: 190-203. PMID 16138857 DOI: 10.1111/j.1399-3011.2005.00289.x  0.52
2005 Shechter Y, Mironchik M, Rubinraut S, Saul A, Tsubery H, Fridkin M. Albumin-insulin conjugate releasing insulin slowly under physiological conditions: a new concept for long-acting insulin. Bioconjugate Chemistry. 16: 913-20. PMID 16029032 DOI: 10.1021/bc050055w  0.52
2005 Dangoor D, Giladi E, Fridkin M, Gozes I. Neuropeptide receptor transcripts are expressed in the rat clitoris and oscillate during the estrus cycle in the rat vagina. Peptides. 26: 2579-84. PMID 16023261 DOI: 10.1016/j.peptides.2005.06.005  0.52
2005 Shacham S, Cheifetz MN, Fridkin M, Pawson AJ, Millar RP, Naor Z. Identification of Ser153 in ICL2 of the gonadotropin-releasing hormone (GnRH) receptor as a phosphorylation-independent site for inhibition of Gq coupling. The Journal of Biological Chemistry. 280: 28981-8. PMID 15964850 DOI: 10.1074/jbc.M500312200  0.52
2005 Shechter Y, Tsubery H, Mironchik M, Rubinstein M, Fridkin M. Reversible PEGylation of peptide YY3-36 prolongs its inhibition of food intake in mice. Febs Letters. 579: 2439-44. PMID 15848185 DOI: 10.1016/j.febslet.2005.03.044  0.52
2005 Zheng H, Weiner LM, Bar-Am O, Epsztejn S, Cabantchik ZI, Warshawsky A, Youdim MB, Fridkin M. Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases. Bioorganic & Medicinal Chemistry. 13: 773-83. PMID 15653345 DOI: 10.1016/j.bmc.2004.10.037  0.52
2005 Rahimipour S, Litichever-Coslovsky N, Alaluf M, Freeman D, Ehrenberg B, Weiner L, Mazur Y, Fridkin M, Koch Y. Novel methyl helianthrones as photosensitizers: synthesis and biological evaluation. Photochemistry and Photobiology. 81: 250-8. PMID 15646998 DOI: 10.1562/2004-07-14-RA-234  0.52
2005 Di-Segni S, Giordano C, Rahimipour S, Ben-Aroya N, Koch Y, Fridkin M. beta-Sulfonamido gonadotropin-releasing hormone analogs: synthesis and evaluation of several parent hormone properties. Journal of Peptide Science : An Official Publication of the European Peptide Society. 11: 45-52. PMID 15635726 DOI: 10.1002/psc.596  0.52
2005 Youdim MB, Fridkin M, Zheng H. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases. Mechanisms of Ageing and Development. 126: 317-26. PMID 15621213 DOI: 10.1016/j.mad.2004.08.023  0.52
2005 Shechter Y, Goldwaser I, Mironchik M, Tsubery H, Fridkin M. Oral therapy of L-glutamic acid γ-monohydroxamate-vanadium (2:1) complex: Improvement of blood glucose profile in different types of diabetic rodents Pure and Applied Chemistry. 77: 1617-1628. DOI: 10.1351/pac200577091617  0.52
2004 Youdim MBH, Fridkin M, Zheng H. Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseases Journal of Neural Transmission. 111: 1455-1471. PMID 15480846 DOI: 10.1007/s00702-004-0143-x  0.52
2004 Kasher R, Gayer B, Kulik T, Somjen D, Venkatesh N, Fridkin M, Katchalski-Katzir E, Kohen F. Design, synthesis, and evaluation of peptides with estrogen-like activity. Biopolymers. 76: 404-20. PMID 15468062 DOI: 10.1002/bip.20133  0.52
2004 Barda Y, Cohen N, Lev V, Ben-Aroya N, Koch Y, Mishani E, Fridkin M, Gilon C. Backbone metal cyclization: novel 99mTc labeled GnRH analog as potential SPECT molecular imaging agent in cancer. Nuclear Medicine and Biology. 31: 921-33. PMID 15464394 DOI: 10.1016/j.nucmedbio.2004.05.003  0.52
2004 Peleg-Shulman T, Tsubery H, Mironchik M, Fridkin M, Schreiber G, Shechter Y. Reversible PEGylation: a novel technology to release native interferon alpha2 over a prolonged time period. Journal of Medicinal Chemistry. 47: 4897-904. PMID 15369394 DOI: 10.1021/jm0497693  0.52
2004 Tsubery H, Mironchik M, Fridkin M, Shechter Y. Prolonging the action of protein and peptide drugs by a novel approach of reversible polyethylene glycol modification. The Journal of Biological Chemistry. 279: 38118-24. PMID 15190059 DOI: 10.1074/jbc.M405155200  0.52
2003 Fuchs S, Kasher R, Balass M, Scherf T, Harel M, Fridkin M, Sussman JL, Katchalski-Katzir E. The binding site of acetylcholine receptor: from synthetic peptides to solution and crystal structure. Annals of the New York Academy of Sciences. 998: 93-100. PMID 14592866 DOI: 10.1196/annals.1254.011  0.52
2003 Gozes I, Divinsky I, Pilzer I, Fridkin M, Brenneman DE, Spier AD. From Vasoactive Intestinal Peptide (VIP) Through Activity-Dependent Neuroprotective Protein (ADNP) to NAP: A View of Neuroprotection and Cell Division Journal of Molecular Neuroscience. 20: 315-322. PMID 14501014 DOI: 10.1385/JMN:20:3:315  0.52
2003 Rahimipour S, Ben-Aroya N, Ziv K, Chen A, Fridkin M, Koch Y. Receptor-mediated targeting of a photosensitizer by its conjugation to gonadotropin-releasing hormone analogues. Journal of Medicinal Chemistry. 46: 3965-74. PMID 12954050 DOI: 10.1021/jm020535y  0.52
2003 Shechter Y, Tsubery H, Fridkin M. Suspensions of pro-drug insulin greatly prolong normoglycemic patterns in diabetic rats. Biochemical and Biophysical Research Communications. 307: 315-21. PMID 12859957 DOI: 10.1016/S0006-291X(03)01200-2  0.52
2003 Shechter Y, Tsubery H, Fridkin M. [2-Sulfo-9-fluorenylmethoxycarbonyl]3-exendin-4-a long-acting glucose-lowering prodrug. Biochemical and Biophysical Research Communications. 305: 386-91. PMID 12745087 DOI: 10.1016/S0006-291X(03)00715-0  0.52
2003 Katchalski-Katzir E, Kasher R, Balass M, Scherf T, Harel M, Fridkin M, Sussman JL, Fuchs S. Design and synthesis of peptides that bind alpha-bungarotoxin with high affinity and mimic the three-dimensional structure of the binding-site of acetylcholine receptor. Biophysical Chemistry. 100: 293-305. PMID 12646372 DOI: 10.1016/S0301-4622(02)00287-9  0.52
2003 Rahimipour S, Palivan C, Barbosa F, Bilkis I, Koch Y, Weiner L, Fridkin M, Mazur Y, Gescheidt G. Chemical and photochemical electron transfer of new helianthrone derivatives: aspects of their photodynamic activity. Journal of the American Chemical Society. 125: 1376-84. PMID 12553841 DOI: 10.1021/ja028189x  0.52
2003 Shechter Y, Goldwaser I, Mironchik M, Fridkin M, Gefel D. Historic perspective and recent developments on the insulin-like actions of vanadium; toward developing vanadium-based drugs for diabetes Coordination Chemistry Reviews. 237: 3-11. DOI: 10.1016/S0010-8545(02)00302-8  0.52
2002 Levy A, Gal R, Granoth R, Dreznik Z, Fridkin M, Gozes I. In vitro and in vivo treatment of colon cancer by VIP antagonists Regulatory Peptides. 109: 127-133. PMID 12409224 DOI: 10.1016/S0167-0115(02)00195-7  0.52
2002 Tsubery H, Ofek I, Cohen S, Eisenstein M, Fridkin M. Modulation of the hydrophobic domain of polymyxin B nonapeptide: effect on outer-membrane permeabilization and lipopolysaccharide neutralization. Molecular Pharmacology. 62: 1036-42. PMID 12391265 DOI: 10.1124/mol.62.5.1036  0.52
2002 Steingart RA, Heldenberg E, Pinhasov A, Brenneman DE, Fridkin M, Gozes I. A vasoactive intestinal peptide receptor analog alters the expression of homeobox genes Life Sciences. 71: 2543-2552. PMID 12270759 DOI: 10.1016/S0024-3205(02)02082-9  0.52
2002 Wollman Y, Blumberg S, Spungin A, Brenneman DE, Fridkin M, Wollman J, Iaina A, Gozes I. The increased proliferation of cultured neuroblastoma cells treated with vasoactive intestinal peptide is enhanced by simultaneous inhibition of neutral endopeptidase Regulatory Peptides. 108: 175-177. PMID 12220742  0.52
2002 Shechter Y, Tsubery H, Fridkin M. N-[(2-Sulfo)-9-fluorenylmethoxycarbonyl](3)-gentamicin C(1) is a long-acting prodrug derivative. Journal of Medicinal Chemistry. 45: 4264-70. PMID 12213067 DOI: 10.1021/jm020042t  0.52
2002 Carmon L, Bobilev-Priel I, Brenner B, Bobilev D, Paz A, Bar-Haim E, Tirosh B, Klein T, Fridkin M, Lemonnier F, Tzehoval E, Eisenbach L. Characterization of novel breast carcinoma-associated BA46-derived peptides in HLA-A2.1/D(b)-beta2m transgenic mice. The Journal of Clinical Investigation. 110: 453-62. PMID 12189239 DOI: 10.1172/JCI14071  0.52
2002 Leker RR, Teichner A, Grigoriadis N, Ovadia H, Brenneman DE, Fridkin M, Giladi E, Romano J, Gozes I. NAP, a femtomolar-acting peptide, protects the brain against ischemic injury by reducing apoptotic death Stroke. 33: 1085-1092. PMID 11935065 DOI: 10.1161/01.STR.0000014207.05597.D7  0.52
2002 Moody TW, Jensen RT, Fridkin M, Gozes I. (N-stearyl, Norleucine17)VIPhybrid is a broad spectrum vasoactive intestinal peptide receptor antagonist Journal of Molecular Neuroscience. 18: 29-35. PMID 11931347 DOI: 10.1385/JMN:18:1-2:29  0.52
2002 Pelled D, Raveh T, Riebeling C, Fridkin M, Berissi H, Futerman AH, Kimchi A. Death-associated protein (DAP) kinase plays a central role in ceramide-induced apoptosis in cultured hippocampal neurons. The Journal of Biological Chemistry. 277: 1957-61. PMID 11709549 DOI: 10.1074/jbc.M104677200  0.52
2001 Xu R, Abramson J, Fridkin M, Pecht I. SH2 domain-containing inositol polyphosphate 5′-phosphatase is the main mediator of the inhibitory action of the mast cell function-associated antigen Journal of Immunology. 167: 6394-6402. PMID 11714805  0.52
2001 Tsubery H, Ofek I, Cohen S, Fridkin M. N-terminal modifications of Polymyxin B nonapeptide and their effect on antibacterial activity Peptides. 22: 1675-1681. PMID 11587796 DOI: 10.1016/S0196-9781(01)00503-4  0.52
2000 Sigalov E, Fridkin M, Brenneman DE, Gozes I. VIP-related protection against iodoacetate toxicity in pheochromocytoma (PC12) cells: A model for ischemic/hypoxic injury Journal of Molecular Neuroscience. 15: 147-154. PMID 11303779 DOI: 10.1385/JMN:15:3:147  0.52
2000 Eilat E, Fridkin M, Mozes E. A peptide based on the CDR1 of a pathogenic anti-DNA antibody is more efficient than its analogs in inhibiting autoreactive T cells Immunobiology. 202: 383-393. PMID 11131154  0.52
2000 Brosh N, Zinger H, Fridkin M, Mozes E. A peptide based on the sequence of the CDR3 of a murine anti-DNA mAb is a better modulator of experimental SLE than its single amino acid-substituted analogs Cellular Immunology. 205: 52-61. PMID 11078607 DOI: 10.1006/cimm.2000.1711  0.52
2000 Tsubery H, Ofek I, Cohen S, Fridkin M. Structure - Function studies of Polymyxin B nonapeptide: Implications to sensitization of Gram-negative bacteria Journal of Medicinal Chemistry. 43: 3085-3092. PMID 10956216 DOI: 10.1021/jm0000057  0.52
2000 Tsubery H, Ofek I, Cohen S, Fridkin M. Structure activity relationship study of polymyxin B nonapeptide Advances in Experimental Medicine and Biology. 479: 219-222. PMID 10897422  0.52
2000 Gershonov E, Goldwaser I, Fridkin M, Shechter Y. A novel approach for a water-soluble long-acting insulin prodrug: Design, preparation, and analysis of [(2-sulfo)-9- fluorenylmethoxycarbonyl]3-insulin Journal of Medicinal Chemistry. 43: 2530-2537. PMID 10891112 DOI: 10.1021/jm990533m  0.52
2000 Granoth R, Fridkin M, Gozes I. VIP and the potent analog, stearyl-Nle17-VIP, induce proliferation of keratinocytes Febs Letters. 475: 78-83. PMID 10858492 DOI: 10.1016/S0014-5793(00)01628-8  0.52
2000 Granoth R, Fridkin M, Rubinraut S, Gozes I. VIP-derived sequences modified by N-terminal stearyl moiety induce cell death: The human keratinocyte as a model Febs Letters. 475: 71-77. PMID 10858491 DOI: 10.1016/S0014-5793(00)01629-X  0.52
2000 Brosh N, Dayan M, Fridkin M, Mozes E. A peptide based on the CDR3 of an anti-DNA antibody of experimental SLE origin is also a dominant T-cell epitope in (NZBXNZW)F1 lupus-prone mice Immunology Letters. 72: 61-68. PMID 10789683 DOI: 10.1016/S0165-2478(00)00161-9  0.52
2000 Tsubery H, Ofek I, Cohen S, Fridkin M. The functional association of polymyxin B with bacterial lipopolysaccharide is stereospecific: Studies on polymyxin B nonapeptide Biochemistry. 39. DOI: 10.1021/bi000386q  0.52
1999 Gozes I, Fridkinb M, Hill JM, Brenneman DE. Pharmaceutical VIP: prospects and problems. Current Medicinal Chemistry. 6: 1019-34. PMID 10519911  0.52
1999 Gershonov E, Shechter Y, Fridkin M. New concept for long-acting insulin: Spontaneous conversion of an inactive modified insulin to the active hormone in circulation: 9- fluorenylmethoxycarbonyl derivative of insulin Diabetes. 48: 1437-1442. PMID 10389850 DOI: 10.2337/diabetes.48.7.1437  0.52
1998 Yavin EJ, Fridkin M. Peptides derived from human C-reactive protein inhibit the enzymatic activities of human leukocyte elastase and cathepsin G: Use of overlapping peptide sequences to identify a unique inhibitor Journal of Peptide Research. 51: 282-289. PMID 9560003  0.52
1997 Bittner S, Fridkin M. N-quinonyl amino acids; Potential structural components for the synthesis of cytotoxic peptides Amino Acids. 13: 75.  0.52
1997 Yavin EJ, Yan L, Desiderio DM, Pontet M, Fridkin M. Inhibition of human leukocyte elastase and cathepsin G by extended peptides and subunits derived from human C-reactive protein Letters in Peptide Science. 4: 157-166.  0.52
1996 Yavin EJ, Eisenstein M, Fridkin M. Binding pockets on the surface of human leukocyte elastase and human leukocyte cathepsin G. Implications to the design of inhibitors derived from human C-reactive protein Biomedical Peptides, Proteins &Amp; Nucleic Acids : Structure, Synthesis &Amp; Biological Activity. 2: 71-78. PMID 9575343  0.52
1996 Yavin EJ, Yan L, Desiderio DM, Fridkin M. Synthetic peptides derived from the sequence of human C-reactive protein inhibit the enzymatic activities of human leukocyte elastase and human leukocyte cathepsin G. International Journal of Peptide and Protein Research. 48: 465-76. PMID 8956080  0.52
1996 Kirshner SL, Zisman E, Fridkin M, Sela M, Mozes E. Altered peptide ligands of a myasthenogenic epitope as modulators of specific T-cell responses Scandinavian Journal of Immunology. 44: 512-521. PMID 8947604  0.52
1996 Preciado-Patt L, Hershkoviz R, Fridkin M, Lider O. Serum amyloid A binds specific extracellular matrix glycoproteins and induces the adhesion of resting CD4+ T cells Journal of Immunology. 156: 1189-1195. PMID 8557997  0.52
1996 Nir O, Fridkin M, Segall Y. Synthesis of stable spirooxyphosphoranes - Potential promoters of catalytic antibodies Phosphorus, Sulfur and Silicon and Related Elements. 109: 241-244.  0.52
1996 Shrestha-Dawadi PB, Bittner S, Fridkin M, Rahimipour S. On the synthesis of naphthoquinonyl heterocyclic amino acids Synthesis. 1468-1472.  0.52
1995 Gozes I, Fridkin M, Brenneman DE. A VIP hybrid antagonist: From developmental neurobiology to clinical applications Cellular and Molecular Neurobiology. 15: 675-687. PMID 8719036 DOI: 10.1007/BF02071131  0.52
1995 Philosof-Oppenheimer R, Pecht I, Fridkin M. The 2,4-dinitrophenyl group for protection of hydroxyl function of tyrosine during solid-phase peptide synthesis International Journal of Peptide and Protein Research. 45: 116-121. PMID 7782158  0.52
1995 Konen-Waisman S, Fridkin M, Cohen IR. Self and foreign 60-kilodalton heat shock protein T cell epitope peptides serve as immunogenic carriers for a T cell-independent sugar antigen Journal of Immunology. 154: 5977-5985. PMID 7538539  0.52
1995 Yavin EJ, Rosen O, Pontet M, Shephard EG, Fridkin M. Proteolysis of human C-reactive protein by neutrophil-derived lysosomal enzymes generates peptides which modulate neutrophil function: Implication to the anti-inflammatory mechanism Letters in Peptide Science. 2: 7-16. DOI: 10.1007/BF00122918  0.52
1995 Gozes I, Fridkin M, Brenneman DE. Stearyl-Nle17-VIP. Noninvasive treatment of impotence, neuroprotective agent Drugs of the Future. 20: 680-685.  0.52
1993 Gressens P, Hill JM, Gozes I, Fridkin M, Brenneman DE. Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos Nature. 362: 155-158. PMID 8383805  0.52
1993 Gozes I, Fridkin M. A fatty neuropeptide: Potential drug for noninvasive impotence treatment in a rat model Obstetrical and Gynecological Survey. 48: 197-200.  0.52
1992 Shephard EG, Kelly SL, Anderson R, Fridkin M. characterization of neutrophil-mediated degradation of human C-reactive protein and identification of the protease Clinical and Experimental Immunology. 87: 509-513. PMID 1544236  0.52
1992 Gozes I, Fridkin M. A fatty neuropeptide. Potential drug for noninvasive impotence treatment in a rat model Journal of Clinical Investigation. 90: 810-814. PMID 1522236  0.52
1992 Shephard EG, Anderson R, Rosen O, Fridkin M. C-reactive protein (CRP) peptides inactivate enolase in human neutrophils leading to depletion of intracellular ATP and inhibition of superoxide generation Immunology. 76: 79-85. PMID 1321093  0.52
1991 Heffetz D, Fridkin M, Zick Y. Generation and use of antibodies to phosphothreonine Methods in Enzymology. 201: 44-53. PMID 1943772  0.52
1991 Koch Y, Werner H, Fridkin M. Hypothalamic hormones in milk. Endocrine Regulations. 25: 128-33. PMID 1683587  0.52
1990 Rosen O, Rubinraut S, Fridkin M. Thiolysis of the 3-nitro-2-pyridinesulfenyl (Npys) protecting group: An approach towards a general deprotection scheme in peptide synthesis International Journal of Peptide and Protein Research. 35: 545-549. PMID 2401596  0.52
1989 Fridkin M, Najjar VA. Tuftsin: its chemistry, biology, and clinical potential Critical Reviews in Biochemistry and Molecular Biology. 24: 1-40. PMID 2667894  0.52
1989 Heffetz D, Fridkin M, Zick Y. Antibodies directed against phosphothreonine residues as potent tools for studying protein phosphorylation European Journal of Biochemistry. 182: 343-348. PMID 2500341  0.52
1989 Fridkin M, Najjar VA. Tuftsin: Its chemistry, biology, and clinical potentia Critical Reviews in Biochemistry and Molecular Biology. 24: 1-40. DOI: 10.3109/10409238909082550  0.52
1988 Dagan S, Tzehoval E, Tartakovsky B, Fridkin M, Feldman M. Antigen-tuftsin conjugate signals interleukin-1 synthesis and secretion Journal of Biological Response Modifiers. 7: 546-558. PMID 3265146  0.52
1988 Buchta R, Gennaro R, Pontet M, Fridkin M, Romeo D. C-reactive protein decreases protein phosphorylation in stimulated human neutrophils Febs Letters. 237: 173-177. PMID 2844586 DOI: 10.1016/0014-5793(88)80195-9  0.52
1988 Dagan S, Tzehoval E, Feldman M, Fridkin M. Tuftsin and tuftsin protein conjugates potentiate immunogenic processes Advances in the Biosciences. 68: 323-327.  0.52
1987 Buchta R, Pontet M, Fridkin M. Binding of C-reactive protein to human neutrophils Febs Letters. 211: 165-168. PMID 3803595 DOI: 10.1016/0014-5793(87)81429-1  0.52
1986 Gozes I, Bodner M, Shani Y, Fridkin M. Structure and expression of the vasoactive intestinal peptide (VIP) gene in a human tumor. Peptides. 7: 1-6. PMID 3748844 DOI: 10.1016/0196-9781(86)90156-7  0.52
1986 Neumann D, Barchan D, Fridkin M, Fuchs S. Analysis of ligand binding to the synthetic dodecapeptide 185-196 of the acetylcholine receptor α subunit Proceedings of the National Academy of Sciences of the United States of America. 83: 9250-9253. PMID 3466185  0.52
1986 Werner H, Amarant T, Fridkin M, Koch Y. Growth hormone releasing factor-like immunoreactivity in human milk. Biochemical and Biophysical Research Communications. 135: 1084-9. PMID 3083812 DOI: 10.1016/0006-291X(86)91039-9  0.52
1986 Buchta R, Fridkin M, Pontet M, Romeo D. Synthetic peptides from C-reactive protein containing tuftsin-related sequences Peptides. 7: 961-968. PMID 3031632 DOI: 10.1016/0196-9781(86)90121-X  0.52
1986 Buchta R, Bondi E, Fridkin M. Peptides related to the calcium binding domains II and III of calmodulin. Synthesis and calmodulin-like features International Journal of Peptide and Protein Research. 28: 289-297. PMID 2946646  0.52
1986 Werner H, Okon E, Fridkin M, Koch Y. Localization of growth hormone-releasing hormone in the human hypothalamus and pituitary stalk. The Journal of Clinical Endocrinology and Metabolism. 63: 47-50. PMID 2872227 DOI: 10.1210/jcem-63-1-47  0.52
1985 Buchta R, Fridkin M. Introduction of the dansyl group into histidine and tyrosine residues in peptides and proteins Biochemical and Biophysical Research Communications. 130: 350-357. PMID 4026836 DOI: 10.1016/0006-291X(85)90424-3  0.52
1985 Ramu A, Fridkin M, Steinherz R. Cross resistance to esters of methotrexate in a doxorubicin-resistant subline of P388 murine leukemia Cancer Chemotherapy and Pharmacology. 15: 31-34. PMID 4006047 DOI: 10.1007/BF00257290  0.52
1985 Bodner M, Fridkin M, Gozes I. Coding sequences for vasoactive intestinal peptide and PHM-27 peptide are located on two adjacent exons in the human genome Proceedings of the National Academy of Sciences of the United States of America. 82: 3548-3551. PMID 2987932  0.52
1985 Werner H, Fridkin M, Aviv D, Koch Y. Immunoreactive and bioactive somatostatin-like material is present in tobacco (Nicotiana tabacum). Peptides. 6: 797-802. PMID 2867523 DOI: 10.1016/0196-9781(85)90304-3  0.52
1985 Neumann D, Gershoni JM, Fridkin M, Fuchs S. Antibodies to synthetic peptides as probes for the binding site on the α subunit of the acetylcholine receptor Proceedings of the National Academy of Sciences of the United States of America. 82: 3490-3493. PMID 2582416  0.52
1984 Gozes I, Bodner M, Shani Y, Fridkin M. Detection of mRNAs containing regulatory peptide coding sequences using synthetic oligodeoxynucleotides Journal of Cellular Biochemistry. 26: 147-156. PMID 6526855 DOI: 10.1002/jcb.240260303  0.52
1984 Gozes I, Bodner M, Shwartz H, Shani Y, Fridkin M. Studies toward the biosynthesis of vasoactive intestinal peptide (VIP) Peptides. 5: 161-166. PMID 6473148 DOI: 10.1016/0196-9781(84)90200-6  0.52
1984 Neumann D, Fridkin M, Fuchs S. Anti-acetylcholine receptor response achieved by immunization with a synthetic peptide from the receptor sequence Biochemical and Biophysical Research Communications. 121: 673-679. PMID 6203534 DOI: 10.1016/0006-291X(84)90234-1  0.52
1983 Knyszynski A, Gottlieb P, Fridkin M. Inhibition by tuftsin of Rauscher virus leukemia development in mice Journal of the National Cancer Institute. 71: 87-90. PMID 6575215  0.52
1983 Gottlieb P, Tzehoval E, Feldman M, Segal S, Fridkin M. Peptide fragments from the tuftsin containing domain of immunoglobulin G synthesis and biological activity Biochemical and Biophysical Research Communications. 115: 193-200. PMID 6311202 DOI: 10.1016/0006-291X(83)90988-9  0.52
1982 Amarant T, Fridkin M, Koch Y. Luteinizing hormone-releasing hormone and thyrotropin-releasing hormone in human and bovine milk. European Journal of Biochemistry / Febs. 127: 647-50. PMID 6816590  0.52
1982 Gottlieb P, Beretz A, Fridkin M. Tuftsin analogs for probing its specific receptor site on phagocytic cells European Journal of Biochemistry. 125: 631-638. PMID 6288377 DOI: 10.1111/j.1432-1033.1982.tb06729.x  0.52
1981 Stern M, Warshawksy A, Fridkin M. Polymeric 2-mercaptopyridine and 2-mercapto-nitrobenzene derivatives. New reagents for peptide synthesis International Journal of Peptide and Protein Research. 17: 531-538. PMID 7309358  0.52
1981 Fridkin M, Gottlieb P. Tuftsin, Thr-Lys-Pro-Arg - Anatomy of an immunologically active peptide Molecular and Cellular Biochemistry. 41: 73-97. PMID 7035869 DOI: 10.1007/BF00225299  0.52
1981 Elkabes S, Fridkin M, Koch Y. Studies on the enzymic degradation of luteinizing hormone releasing hormone by rat pituitary plasma membranes. Biochemical and Biophysical Research Communications. 103: 240-8. PMID 7032522 DOI: 10.1016/0006-291X(81)91685-5  0.52
1981 Hazum E, Fridkin M, Baram T, Koch Y. Degradation of gonadotropin-releasing hormone by anterior pituitary enzymes. Febs Letters. 127: 273-6. PMID 7016593 DOI: 10.1016/0014-5793(81)80222-0  0.52
1981 Hazum E, Fridkin M, Baram T, Koch Y. Synthesis, biological activity and resistance to enzymic degradation of luteinizing hormone--releasing hormone analogues modified at position 7. Febs Letters. 123: 300-2. PMID 7014245 DOI: 10.1016/0014-5793(81)80313-4  0.52
1980 Stabinsky Y, Gottlieb P, Fridkin M. The phagocytosis stimulating peptide tuftsin: Further look into structure-function relationships Molecular and Cellular Biochemistry. 30: 165-170. PMID 6893216 DOI: 10.1007/BF00230170  0.52
1980 Stabinsky Y, Bar-Shavit Z, Fridkin M, Goldman R. On the mechanism of action of the phagocytosis-stimulating peptide tuftsin Molecular and Cellular Biochemistry. 30: 71-77. PMID 6247642 DOI: 10.1007/BF00227920  0.52
1980 Segal S, Tzehoval E, Fridkin M, Feldman M. What signals macrophages to signal lymphocytes? Behring Institute Mitteilungen. 87-93.  0.52
1979 Stern M, Warshawsky A, Fridkin M. Facile thiolytic removal of the o-nitrophenylsulphenyl amino-protecting group International Journal of Peptide and Protein Research. 13: 315-319. PMID 429104  0.52
1979 Bar‐Shavit Z, Stabinsky Y, Fridkin M, Goldman R. Tuftsin-macrophage interaction: Specific binding and augmentation of phagocytosis Journal of Cellular Physiology. 100: 55-62. PMID 381320 DOI: 10.1002/jcp.1041000106  0.52
1979 Goren HJ, Fridkin M, Katchalskikatzir E, Lotan N. Conformational changes of poly(L‐histidyl‐L‐alanyl‐α‐L‐glutamic acid) in solution. Transition pathways and conformational intermediates Biopolymers. 18: 981-993. DOI: 10.1002/bip.1979.360180416  0.52
1978 Goren HJ, Fridkin M. Thiolysis of Nim-2,4-dinitrophenyl-histidine peptides with 2-mercaptoethanol. An explannation for the pH optimum International Journal of Peptide and Protein Research. 11: 1-8. PMID 631983  0.52
1978 Stabinsky Y, Fridkin M, Zakuth V, Spirer Z. Synthesis and biological activity of tuftsin and of [O = C Thr1]-tuftsin. A novel synthetic route to peptides containing N-terminal L -O = C Thr and L - O = C Ser residues International Journal of Peptide and Protein Research. 12: 130-138. PMID 581282  0.52
1978 Hazum E, Fridkin M, Meidan R, Koch Y. Mercuration of tryptophan in luteinizing hormone-releasing hormone International Journal of Biochemistry. 9: 385-388. PMID 352765 DOI: 10.1016/0020-711X(78)90050-2  0.52
1978 Goren HJ, Fletcher T, Fridkin M, Katchalski-Katzir E. Poly(l-histidyl-l-alanyl-α-l-glutamic acid). II. Catalysis of p-nitrophenyl acetate hydrolysis Biopolymers. 17: 1679-1692. DOI: 10.1002/bip.1978.360170706  0.52
1978 Goren HJ, Fridkin M. Thiolysis of N(im)-2,4-dinitrophenyl-histidine peptides with 2-mercaptoethanol International Journal of Peptide and Protein Research. 11: 1-8.  0.52
1977 Goren HJ, Katchalski-Katzir E, Fridkin M. Poly(L-histidyl-L-alanyl-alpha-L-glutamic acid). I. Synthesis. Biopolymers. 16: 2265-79. PMID 912000 DOI: 10.1002/bip.1977.360161013  0.52
1977 Amit B, Hazum E, Fridkin M, Patchornik A. A photolabile protecting group for the phenolic hydroxyl function of tyrosine. International Journal of Peptide and Protein Research. 9: 91-6. PMID 838537  0.52
1977 Spirer Z, Zakuth V, Bogair N, Fridkin M. Radioimmunoassay of the phagocytosis stimulating peptide tuftsin in normal and splenectomized subjects European Journal of Immunology. 7: 69-74. PMID 577481  0.52
1977 Fridkin M, Stabinsky Y, Zakuth V, Spirer Z. Tuftsin and some analogs. Synthesis and interaction with human polymorphonuclear leukocytes Bba - General Subjects. 496: 203-211. PMID 576412 DOI: 10.1016/0304-4165(77)90129-5  0.52
1977 Koch Y, Baram T, Hazum E, Fridkin M. Purification of the gonadotropin-releasing hormone-degrading enzyme by affinity chromatography. Endocrine Research Communications. 4: 247-55. PMID 344037 DOI: 10.3109/07435807709052944  0.52
1977 Hazum E, Fridkin M, Meidan R, Koch Y. On the role of tryptophan in luteinizing-hormone-releasing hormone (luliberin). European Journal of Biochemistry / Febs. 79: 269-73. PMID 334545  0.52
1977 Baram T, Koch Y, Hazum E, Fridkin M. Gonadotropin-releasing hormone in milk. Science (New York, N.Y.). 198: 300-2. PMID 333582  0.52
1977 Hazum E, Fridkin M, Meidan R, Koch Y. On the function of arginine in luteinizing hormone-releasing hormone. Febs Letters. 76: 187-90. PMID 324800 DOI: 10.1016/0014-5793(77)80148-8  0.52
1977 Koch Y, Baram T, Hazum E, Fridkin M. Resistance to enzymic degradation of LH-RH analogues possessing increased biological activity. Biochemical and Biophysical Research Communications. 74: 488-91. PMID 319798 DOI: 10.1016/0006-291X(77)90330-8  0.52
1977 Fridkin M, Hazum E, Tauber-Finkelstein M, Shaltiel S. Thiolysis of O-2,4-dinitrophenyltyrosines. Spectrophotometric monitoring of the reaction and its use in peptide synthesis Archives of Biochemistry and Biophysics. 178: 517-526. PMID 13733 DOI: 10.1016/0003-9861(77)90222-3  0.52
1977 Fridkin M, Hazum E, Kalir R, Rotman M, Koch Y. Polymeric reagent synthesis of luteinizing hormone-releasing hormone - Comparison with a conventional stepwise preparation Journal of Solid-Phase Biochemistry. 2: 175-182. DOI: 10.1007/BF02991406  0.52
1977 Stern M, Kalir R, Patchornik A, Warshawsky A, Fridkin M. Toward mechanized peptide synthesis via polymeric reagents approach Journal of Solid-Phase Biochemistry. 2: 131-139. DOI: 10.1007/BF02991403  0.52
1977 Hazum E, Fridkin M, Meidan R, Koch Y. Selective mercuration of gonadotropin releasing hormone Israel Journal of Medical Sciences. 13: 930.  0.52
1976 Koch Y, Baram T, Fridkin M. Generation of specific antiserum to thyrotropin releasing-hormone and its use in a radioimmunoassay. Febs Letters. 63: 295-8. PMID 816673 DOI: 10.1016/0014-5793(76)80115-9  0.52
1976 Shinitzky M, Hazum E, Fridkin M. Structure-activity relationships of luliberin substituted at position 8 Bba - Protein Structure. 453: 553-557. PMID 11831 DOI: 10.1016/0005-2795(76)90152-5  0.52
1976 Shinitzky M, Fridkin M. Structural features of luliberin (luteinising hormone-releasing factor) inferred from fluorescence measurements Bba - Protein Structure. 434: 137-143. PMID 7307 DOI: 10.1016/0005-2795(76)90043-X  0.52
1975 Kalir R, Warshawsky A, Fridkin M, Patchornik A. New useful reagents for peptide synthesis. Insoluble active esters of polystyrene-bound 1-hydroxybenzotriazole. European Journal of Biochemistry / Febs. 59: 55-61. PMID 1204619 DOI: 10.1111/j.1432-1033.1975.tb02424.x  0.52
1974 Kalir R, Fridkin M, Patchornik A. (4-Hydroxy-3-nitro)benzylated polystyrene. An improved polymeric nitrophenol derivative for peptide synthesis. European Journal of Biochemistry / Febs. 42: 151-6. PMID 4830188  0.52
1974 Fridkin M, Goren HJ. Synthesis and catalytic properties of the heptapeptide L seryl L prolyl L cysteinyl L seryl α L glutamyl L threomyl L tyrosine European Journal of Biochemistry. 41: 273-283. PMID 4816897  0.52
1974 Goren HJ, Fridkin M. The hydrolysis of p nitrophenylacetate in water. Mechanism and method of measurement European Journal of Biochemistry. 41: 263-272. PMID 4816896  0.52
1974 Koch Y, Baram T, Chobsieng P, Fridkin M. Enzymic degradation of luteinizing hormone-releasing hormone (LH-RH) by hypothalamic tissue. Biochemical and Biophysical Research Communications. 61: 95-103. PMID 4613355 DOI: 10.1016/0006-291X(74)90539-7  0.52
1974 Fridkin M, Patchornik A. Peptide synthesis. Annual Review of Biochemistry. 43: 419-43. PMID 4369000 DOI: 10.1146/annurev.bi.43.070174.002223  0.52
1973 Agarwal KL, Fridkin M, Jay E, Khorana HG. Deoxyoligonucleotide synthesis using a new phosphate protecting group [9] Journal of the American Chemical Society. 95: 2020-2021. PMID 4689925  0.52
1972 Fridkin M, Patchornik A, Katchalski E. Peptide synthesis by means of tert-butyloxycarbonylamino acid derivatives of poly(ethylene-co-N-hydroxymaleimide). Biochemistry. 11: 466-71. PMID 5059124  0.52
1971 Fridkin M, Shaltiel S. A new route to polyamino acids containing histidine Archives of Biochemistry and Biophysics. 147: 767-771. PMID 5136109 DOI: 10.1016/0003-9861(71)90437-1  0.52
1971 Kaufmann G, Fridkin M, Zutra A, Littauer UZ. Monofunctional substrates of polynucleotide phosphorylase. The monoaddition of 2'(3')-O-isovaleryl-nucleoside diphosphate to an initiator oligonucleotide. European Journal of Biochemistry / Febs. 24: 4-11. PMID 4944991 DOI: 10.1111/j.1432-1033.1971.tb19649.x  0.52
1970 Wilchek M, Fridkin M, Patchornik A. Nonaqueous titrimetric determination of active esters of amino acids and peptide derivatives. Analytical Chemistry. 42: 275-7. PMID 5522281  0.52
1970 Shaltiel S, Fridkin M. Thiolysis of dinitrophenylimidazoles and its use during synthesis of histidine peptides Biochemistry. 9: 5122-5127. PMID 5482653  0.52
1970 Fridkin M, Wilchek M, Sheinblatt M. NMR studies of H-D exchange of α-CH group of amino acid residues in peptides Biochemical and Biophysical Research Communications. 38: 458-464. PMID 5443693 DOI: 10.1016/0006-291X(70)90735-7  0.52
1970 Goren HJ, Fridkin M. The detection of peptide hydrazides on thin-layer chromatograms Journal of Chromatography A. 47: 519-523. PMID 5441109 DOI: 10.1016/0021-9673(70)80083-8  0.52
1970 Fridkin M, Goren HJ. Volumetric determination of amino acid and peptide hydrazides Experientia. 26: 561-562. PMID 4315530 DOI: 10.1007/BF01898515  0.52
1970 Fridkin M, Goren HJ. Detection of peptide active esters by thin-layer chromatography Analytical Biochemistry. 37: 450-457. PMID 4097671 DOI: 10.1016/0003-2697(70)90072-2  0.52
1969 Fridkin M, Frenkel A, Ariely S. Poly(L‐leucyl‐L‐ornithyl‐L‐leucine) and its Guanidization Product: Synthesis and Antibacterial Activity Biopolymers. 8: 661-668. PMID 5362530 DOI: 10.1002/bip.1969.360080508  0.52
1969 Shinitzky M, Fridkin M. Spectral Studies with Histidyl‐Tryptophan Peptides European Journal of Biochemistry. 9: 176-181. PMID 4240954 DOI: 10.1111/j.1432-1033.1969.tb00592.x  0.52
1969 Ariely S, Fridkin M, Patchornik A. Synthesis of poly‐L‐asparagine and poly‐L‐glutamine Biopolymers. 7: 417-422. DOI: 10.1002/bip.1969.360070312  0.52
1968 Burstein Y, Fridkin M, Shinitzky M. Detection of aromatic amino acid derivatives on thin-layer chromatograms by various electron acceptors Bba - Protein Structure. 160: 141-144. PMID 5658117  0.52
1968 Fridkin M, Patchornik A, Katchalski E. Use of polymers as chemical reagents. II. Synthesis of bradykinin. Journal of the American Chemical Society. 90: 2953-7. PMID 5648112  0.52
1966 Fridkin M, Patchornik A, Katchalski E. Use of polymers as chemical reagents. I. Preparation of peptides [27] Journal of the American Chemical Society. 88: 3164-3165.  0.52
1965 Fridkin M, Patchornik A, Katchalski E. A synthesis of cyclic peptides utilizing high molecular weight carriers [6] Journal of the American Chemical Society. 87: 4646-4648.  0.52
1964 Fridkin M, Sokolovsky M, Katchalski E. Synthesis of tritiated poly‐L‐lysine (γ, δ‐T2) Biopolymers. 2: 123-129. DOI: 10.1002/bip.1964.360020204  0.52
Show low-probability matches.